(E)-3-(2-Fluorophenyl)-N-(1H-indol-5-yl)acrylamide 10 mg | ≥98% Cayman Chemical A MAO-B inhibitor and Nrf2 inducer More Information Supplier Page × (E)-3-(2-Fluorophenyl)-N-(1H-indol-5-yl)acrylamide
(E)-3-(2-Fluorophenyl)-N-(1H-indol-5-yl)acrylamide 1 mg | ≥98% Cayman Chemical A MAO-B inhibitor and Nrf2 inducer More Information Supplier Page × (E)-3-(2-Fluorophenyl)-N-(1H-indol-5-yl)acrylamide
4-Benzyl Salbutamol 5 mg | ≥98% Cayman Chemical An intermediate in the synthesis of salbutamol More Information Supplier Page × 4-Benzyl Salbutamol
4-Benzyl Salbutamol 25 mg | ≥98% Cayman Chemical An intermediate in the synthesis of salbutamol More Information Supplier Page × 4-Benzyl Salbutamol
4-Benzyl Salbutamol 10 mg | ≥98% Cayman Chemical An intermediate in the synthesis of salbutamol More Information Supplier Page × 4-Benzyl Salbutamol
4-Benzyl Salbutamol 1 mg | ≥98% Cayman Chemical An intermediate in the synthesis of salbutamol More Information Supplier Page × 4-Benzyl Salbutamol
Elinzanetant 50 mg | ≥98% Cayman Chemical A dual NK1 and NK3 receptor antagonist More Information Supplier Page × Elinzanetant
Elinzanetant 5 mg | ≥98% Cayman Chemical A dual NK1 and NK3 receptor antagonist More Information Supplier Page × Elinzanetant
Elinzanetant 25 mg | ≥98% Cayman Chemical A dual NK1 and NK3 receptor antagonist More Information Supplier Page × Elinzanetant
Elinzanetant 10 mg | ≥98% Cayman Chemical A dual NK1 and NK3 receptor antagonist More Information Supplier Page × Elinzanetant
